Search

Your search keyword '"C. Rubio Rodriguez"' showing total 23 results
Start Over Author "C. Rubio Rodriguez"
23 results on '"C. Rubio Rodriguez"'

1. PO-1337 Long Follow Up Of Late Toxicity After Hypofractionated Postoperative Radiation In Prostate Cancer

Author

A. Montero Luis, K.D. Rossi Coronado, M. Izquierdo Merchán, B. Álvarez Rodríguez, C. Rubio Rodriguez, A. Prado Barragán, R. Ciervide Jurio, R. Alonso, O. Hernando Requejo, M. Garcia-Aranda Pez, P. Fernandez Leton, J. Valero, M. Lopez Gonzalez, M. Nuñez Baez, E. Sanchez Saugar, Xiaoyun Chen, and J. Martí Asenjo

Subjects
Late toxicity, medicine.medical_specialty, Prostate cancer, Oncology, business.industry, Postoperative radiation, Urology, Medicine, Radiology, Nuclear Medicine and imaging, Hematology, business, medicine.disease
Published
2021
Full Text
View/download PDF

2. EP-1981 Intrafractional baseline drift in SBRT of lung tumors

Author

C. Rubio Rodriguez, J. García Ruiz-Zorrilla, O. Hernando Requejo, J. M. Perez Moreno, D. Zucca Aparicio, J. Martí Asenjo, P. Fernandez Leton, Xiaoyun Chen, P. García de Acilu Laa, and M. A. de la Casa de Julian

Subjects
Lung, medicine.anatomical_structure, Oncology, business.industry, medicine, Radiology, Nuclear Medicine and imaging, Hematology, Nuclear medicine, business, Baseline drift
Published
2019
Full Text
View/download PDF

4. EP-1474: IMRT and Integrated-boost as neoadjuvant chemoradiation for rectal cancer

Author

P. Fernandez Leton, M. Lopez Gonzalez, M. Garcia Aranda, A. Montero Luis, R. Ciervide Jurio, O. Hernando Requejo, J. Valero Albarran, J. M. Perez Moreno, A. Cubillo Gracian, C. Rubio Rodriguez, E. Sanchez Saugar, J. Rodriguez Pascual, Y. Quijano Collazo, E. Vicente Lopez, S. Gonzalo Ruiz, and R. Alonso Gutierrez

Subjects
medicine.medical_specialty, Oncology, Colorectal cancer, business.industry, medicine, Radiology, Nuclear Medicine and imaging, Hematology, Radiology, medicine.disease, business
Published
2018
Full Text
View/download PDF

7. EP-2035: Intrafractional baseline drift in SBRT of pancreas tumors

Author

C. Rubio Rodriguez, O. Hernando Requejo, M. A. de la Casa de Julian, J. Martí Asenjo, M. Lopez Gonzalez, J. García Ruiz-Zorrilla, P. Fernandez Leton, and D. Zucca Aparicio

Subjects
Oncology, business.industry, Pancreatic tumor, Medicine, Radiology, Nuclear Medicine and imaging, Hematology, business, medicine.disease, Nuclear medicine, Baseline drift
Published
2018
Full Text
View/download PDF

8. EP-2029: Intrafractional baseline drift in SBRT of liver tumors

Author

C. Rubio Rodriguez, O. Hernando Requejo, M. A. de la Casa de Julian, P. Fernandez Leton, B. Álvarez Rodríguez, J. Valero Albarran, J. García Ruiz-Zorrilla, X. Chen Zhao, R. Ciervide Jurio, D. Zucca Aparicio, and J. Martí Asenjo

Subjects
Oncology, business.industry, Medicine, Radiology, Nuclear Medicine and imaging, Hematology, Nuclear medicine, business, Baseline drift
Published
2018
Full Text
View/download PDF

9. Treatment of lung lesions by stereotactic body radiation therapy after computed tomography guided placement of a Visicoil® marker: Initial experience

Author

M. Fernández-Velilla Peña, A. Muro de la Fuente, O. Hernando Requejo, M. Torres Sanchez, E. Sanchez Saugar, M. Allona Krauel, and C. Rubio Rodriguez

Subjects
medicine.medical_specialty, Lung, Percutaneous, business.industry, medicine.medical_treatment, medicine.disease, Radiosurgery, Lesion, medicine.anatomical_structure, Pneumothorax, General Earth and Planetary Sciences, Medicine, Radiology, medicine.symptom, business, Fiducial marker, Lung cancer, General Environmental Science, Pneumonitis
Abstract

Objective To describe the technique of stereotactic body radiation therapy (SBRT) of lung lesions after the computed tomography (CT) guided placement of an internal fiducial marker and to assess the results, complications and secondary effects of these procedures. Materials and methods A series of 39 lesions (8 primary and 31 metastases) in 25 patients treated using this procedure were analyzed. A CT-guided percutaneous transthoracic puncture was performed for placing the internal marker in the lesion or near to it. The procedure did not require sedation. The marker serves as a guide for the treatment of the lesion using SBRT with respiratory synchronism, which allows the movement of the tumor to be controlled and to decrease the radiation volume, giving high doses with precision to the tumor, and minimal to the surrounding healthy tissue. Results The only complication of the percutaneous fiducial placement was a pneumothorax in 6 (24%) patients. A pleural drain had to be placed in 3 patients. Local control was achieved in 96.7% of the lesions. The radiation produced a Grade 1 asthenia in 1 patient, a Grade 2 pneumonitis in one patient and a Grade 1 pneumonitis in the remainder. Conclusions The CT-guided placement of internal markers in lung lesions is a safe technique that may be performed as ambulatory procedure. SBRT with respiratory synchronism allows the dose to the tumor to be increased, and reduces the volume of healthy lung treated, with few secondary effects.

Published
2013
Full Text
View/download PDF

11. Frameless image-guided intracranial stereotactic radiosurgery

Author

O. Hernando Requejo, J. Valero Albarran, M. Garcia-Aranda Pez, M. Lopez Gonzalez, R. Ciervide Jurio, G. Potdevin, C. Rubio Rodriguez, A. Rodríguez, and E. Sanchez Saugar

Subjects
Cancer Research, Oncology, business.industry, Radiology Nuclear Medicine and imaging, medicine.medical_treatment, medicine, Radiology, Nuclear Medicine and imaging, business, Nuclear medicine, Radiosurgery
Published
2013
Full Text
View/download PDF

12. EP-1385: Hypofraccionated stereotactic reirradiation with Novalis linac in patients with high-grade gliomas

Author

R. Ciervide Jurio, C. Etto Valdovinos, M. Lopez Gonzalez, C. Belda Iniesta, M. Garcia-AAranda Pez, E. Sanchez Saugar, O. Hernando Requejo, C. Rubio Rodriguez, J. Valero Albarran, and A. Ortiz de Mendevil

Subjects
Oncology, business.industry, Medicine, Radiology, Nuclear Medicine and imaging, In patient, Hematology, Nuclear medicine, business
Published
2014
Full Text
View/download PDF

13. PO-136: 7-year experience with the use of PEG in head and neck cancer patients treated with Radiation Therapy

Author

A. Gomez Pinillos, M. Garcia-Aranda Pez, C. Rubio Rodriguez, D. Zucca Aparicio, O. Hernando Requejo, A. Rodriguez Gutierrez, R. Ciervide Jurio, M. L. Lopez Rodriguez, E. Sanchez Saugar, and J. Valero Albarran

Subjects
Oncology, medicine.medical_specialty, business.industry, medicine.medical_treatment, Head and neck cancer, Hematology, medicine.disease, Radiation therapy, Internal medicine, PEG ratio, medicine, Radiology, Nuclear Medicine and imaging, Radiology, business
Published
2015
Full Text
View/download PDF

14. PO-072: 7-year experience of 18FDG PET-CT, IMRT and IGRT in Nasopharyngeal carcinoma (NC)

Author

O. Hernando Requejo, C. Rubio Rodriguez, D. Zucca Aparicio, A. Gomez Pinillos, M. Garcia-Aranda Pez, E. Sanchez Saugar, A. Rodriguez Gutierrez, J. Valero Albarran, M. L. Lopez Rodriguez, and R. Ciervide Jurio

Subjects
Oncology, medicine.medical_specialty, business.industry, Hematology, 18fdg pet ct, medicine.disease, Nasopharyngeal carcinoma, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, business, Nuclear medicine, Image-guided radiation therapy
Published
2015
Full Text
View/download PDF

15. Single center experience on vertebral radiosurgery with novalis and IMRT/IGRT

Author

R. Ciervide Jurio, A. Rodriguez Gutierrez, O. Hernando Requejo, G. Potdevin Stein, J. Valero, E. Sanchez Saugar, C. Rubio Rodriguez, M. Lopez, and M. Garcia-Aranda

Subjects
medicine.medical_specialty, Cancer Research, Oncology, business.industry, Radiology Nuclear Medicine and imaging, medicine.medical_treatment, medicine, Radiology, Nuclear Medicine and imaging, Medical physics, Single Center, business, Radiosurgery, Image-guided radiation therapy
Published
2013
Full Text
View/download PDF

16. Treatment of lung and liver lesions with SBRT and respiratory gating

Author

G. Potdevin Stein, E. Sanchez, M. Lopez, Raquel Ciérvide, A. Rodriguez Gutierrez, J. Valero, C. Rubio Rodriguez, O. Hernando Requejo, and M. Garcia-Aranda

Subjects
Cancer Research, medicine.medical_specialty, Lung, medicine.anatomical_structure, Oncology, Radiology Nuclear Medicine and imaging, business.industry, Respiratory gating, medicine, Radiology, Nuclear Medicine and imaging, Radiology, business
Published
2013
Full Text
View/download PDF

17. 3D-radiotherapy with multiple fields and hypofractionated treatment in breast cancer

Author

A. Rodriguez Gutierrez, J. Valero, M. Lopez, M. Garcia-Aranda, R. Ciervide Jurio, G. Potdevin Stein, E. Sanchez Saugar, O. Hernando Requejo, and C. Rubio Rodriguez

Subjects
Oncology, medicine.medical_specialty, Cancer Research, business.industry, medicine.medical_treatment, medicine.disease, Radiation therapy, Breast cancer, Radiology Nuclear Medicine and imaging, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, business
Published
2013
Full Text
View/download PDF

18. EP-1298: Imaged guided IMRT & moderate hypofractionated for the treament of prostate cancer in novalis linac

Author

R. Ciervide Jurio, A. Rodriguez Gutierrez, O. Hernando Requejo, M. Lopez Gonzalez, C. Rubio Rodriguez, J. M. Perez Moreno, E. Sanchez Saugar, J. Valero Albarran, and M. Garcia-Aranda

Subjects
Prostate cancer, Oncology, business.industry, Medicine, Radiology, Nuclear Medicine and imaging, Hematology, business, medicine.disease, Nuclear medicine
Published
2014
Full Text
View/download PDF

19. EP-1199: Hypofractionated radiotherapy and concomitant boost in breast cancer patients using 3-D conformal radiotherapy

Author

M. Lopez Gonzalez, M. Garcia-Aranda Pez, C. Eito Valdovinos, E. Sanchez Aggar, C. Rubio Rodriguez, R. Ciervide Jurio, L. García Estevez, O. Hernando Requejo, J. Valero Albarran, and M. Herrero Conde

Subjects
Oncology, Hypofractionated Radiotherapy, medicine.medical_specialty, business.industry, Concomitant boost, Hematology, Conformal radiotherapy, medicine.disease, Breast cancer, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, business
Published
2014
Full Text
View/download PDF

20. Experience with IMRT and integrated boost in anal canal carcinoma

Author

M. Lopez Gonzalez, C. Rubio Rodriguez, G. Potdevin Stein, A. Rodriguez Gutierrez, M. Garcia-Aranda Pez, E. Sanchez Saugar, R. Ciervide Jurio, O. Hernando Requejo, and J. Valero Albarran

Subjects
Oncology, Cancer Research, medicine.medical_specialty, Radiology Nuclear Medicine and imaging, business.industry, Internal medicine, Medicine, Radiology, Nuclear Medicine and imaging, Radiology, business, ANAL CANAL CARCINOMA
Published
2013
Full Text
View/download PDF

21. Improve pathological response with neoadjuvant IMRT for rectal cancer

Author

G. Potdevin Stein, E. Sanchez Saugar, O. Hernando Requejo, A. Rodriguez Gutierrez, C. Rubio Rodriguez, J. Valero Albarran, M. Garcia-Aranda Pez, M. Lopez Gonzalez, and R. Ciervide Jurio

Subjects
Oncology, medicine.medical_specialty, Cancer Research, Colorectal cancer, business.industry, Radiology Nuclear Medicine and imaging, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, Pathological response, medicine.disease, business
Full Text
View/download PDF

22. Prospective study of partial breast irradiation (PBI) with stereotactic body radiation therapy (SBRT) with Exactrac Adaptive Gating in patients with breast cancer of very good prognosis (VGP)

Author

O. Hernando Requejo, M. López, M. Garcia-Aranda, J. Valero, G. Potdevin Stein, E. Sanchez Saugar, R. Ciervide Jurio, A. Rodriguez Gutierrez, and C. Rubio Rodriguez

Subjects
Cancer Research, Stereotactic body radiation therapy, business.industry, Partial Breast Irradiation, Gating, medicine.disease, Breast cancer, Oncology, Radiology Nuclear Medicine and imaging, medicine, Radiology, Nuclear Medicine and imaging, In patient, Good prognosis, Nuclear medicine, business, Prospective cohort study
Full Text
View/download PDF

23. Radiotherapy for metastatic spinal cord compression with increased radiation doses (RAMSES-01): a prospective multicenter study.

Author

Rades D, Hansen O, Jensen LH, Dziggel L, Staackmann C, Doemer C, Cacicedo J, Conde-Moreno AJ, Segedin B, Ciervide-Jurio R, Rubio-Rodriguez C, Perez-Romasanta LA, Alvarez-Gracia A, Dennis K, Ferrer-Albiach C, Navarro-Martin A, Lopez-Campos F, Jankarashvili N, Janssen S, Olbrich D, and Holländer NH

Subjects
Clinical Trials as Topic, Dose-Response Relationship, Radiation, Humans, Radiation Injuries, Radiosurgery adverse effects, Radiosurgery methods, Radiotherapy, Intensity-Modulated adverse effects, Radiotherapy, Intensity-Modulated methods, Spinal Cord Compression pathology, Survival Analysis, Dose Fractionation, Radiation, Spinal Cord Compression radiotherapy, Spinal Neoplasms radiotherapy, Spinal Neoplasms secondary
Abstract

Background: Patients with metastatic spinal cord compression (MSCC) and favorable survival prognoses can benefit from radiation doses greater than 30Gy in 10 fractions in terms of improved local progression-free survival (LPFS) and overall survival (OS)., Methods/design: This prospective study mainly investigates LPFS after precision radiotherapy (volumetric modulated arc therapy or stereotactic body radiotherapy) with 18 × 2.33Gy in 3.5 weeks. LPFS is defined as freedom from progression of motor deficits during radiotherapy and an in-field recurrence of MSCC following radiotherapy. The maximum relative dose allowed to the spinal cord is 101.5% of the prescribed dose, resulting in an equivalent dose in 2Gy-fractions (EQD2) for radiation myelopathy is 45.5Gy, which is below the tolerance dose of 50Gy according to the Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC). The EQD2 of this regimen for tumor cell kill is 43.1Gy, which is 33% higher than for 30Gy in 10 fractions (EQD2 = 32.5Gy). Primary endpoint is LPFS at 12 months after radiotherapy. Secondary endpoints include the effect of 18 × 2.33Gy on motor function, ambulatory status, sensory function, sphincter dysfunction, LPFS at other follow-up times, overall survival, pain relief, relief of distress and toxicity. Follow-up visits for all endpoints will be performed directly and at 1, 3, 6, 9 and 12 months after radiotherapy. A total of 65 patients are required for the prospective part of the study. These patients will be compared to a historical control group of at least 235 patients receiving conventional radiotherapy with 10x3Gy in 2 weeks., Discussion: If precision radiotherapy with 18 × 2.33Gy results in significantly better LPFS than 10x3Gy of conventional radiotherapy, this regimen should be strongly considered for patients with MSCC and favorable survival prognoses., Trial Registration: Clinicaltrials.gov NCT04043156. Registered 30-07-2019.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results